Efficacy and Immunogenicity of a Recombinant Vesicular Stomatitis Virus-Vectored Marburg Vaccine in Cynomolgus Macaques
Viruses · 2024
DOI: 10.3390/v16081181 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Vidyleison N Camargos und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA. Hauptthemen laut MEDLINE: Macaca fascicularis, Marburg Virus Disease, Marburgvirus, Viral Vaccines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Health and Human Services; Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Authority, Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response.
Abstract (Originalsprache)
Filoviruses, like the Marburg (MARV) and Ebola (EBOV) viruses, have caused outbreaks associated with significant hemorrhagic morbidity and high fatality rates. Vaccines offer one of the best countermeasures for fatal infection, but to date only the EBOV vaccine has received FDA licensure. Given the limited cross protection between the EBOV vaccine and Marburg hemorrhagic fever (MHF), we analyzed the protective efficacy of a similar vaccine, rVSV-MARV, in the lethal cynomolgus macaque model. NHPs vaccinated with a single dose (as little as 1.6 × 107 pfu) of rVSV-MARV seroconverted to MARV G-protein prior to challenge on day 42. Vaccinemia was measured in all vaccinated primates, self-resolved by day 14 post vaccination. Importantly, all vaccinated NHPs survived lethal MARV challenge, and showed no significant alterations in key markers of morbid disease, including clinical signs, and certain hematological and clinical chemistry parameters. Further, apart from one primate (from which tissues were not collected and no causal link was established), no pathology associated with Marburg disease was observed in vaccinated animals. Taken together, rVSV-MARV is a safe and efficacious vaccine against MHF in cynomolgus macaques.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA.
- Departments of Pathology, Microbiology and Immunology, Institute of Human Infection and Immunity, University of Texas Medical Branch, Galveston, TX 77555, USA.
- Departments of Pathology, Center for Vector-Borne and Zoonotic Diseases, Institute of Human Infection and Immunity, University of Texas Medical Branch, Galveston, TX 77555, USA.
- Public Health Vaccines, LLC, Cambridge, MA 02142, USA.
ORCID-Profile: Vidyleison N Camargos, Terry L Juelich, Nikos Vasilakis, Alexander N Freiberg, Rick Nichols, Joan Fusco
Förderung
- Department of Health and Human Services; Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Authority
- Department of Health and Human Services
- Office of the Assistant Secretary for Preparedness and Response
- Biomedical Advanced Research and Development Authority
Zitieren
APA
Camargos, V. N., Rossi, S. L., Juelich, T. L., Smith, J. K., Vasilakis, N., Freiberg, A. N., Nichols, R., & Fusco, J. (2024). Efficacy and Immunogenicity of a Recombinant Vesicular Stomatitis Virus-Vectored Marburg Vaccine in Cynomolgus Macaques. Viruses. https://doi.org/10.3390/v16081181
Vancouver
Camargos VN, Rossi SL, Juelich TL, Smith JK, Vasilakis N, Freiberg AN, et al. Efficacy and Immunogenicity of a Recombinant Vesicular Stomatitis Virus-Vectored Marburg Vaccine in Cynomolgus Macaques. Viruses. 2024. doi:10.3390/v16081181
BibTeX
@article{Camargos2024,
author = {Camargos, Vidyleison N and Rossi, Shannan L and Juelich, Terry L and Smith, Jennifer K and Vasilakis, Nikos and Freiberg, Alexander N and Nichols, Rick and Fusco, Joan},
title = {Efficacy and Immunogenicity of a Recombinant Vesicular Stomatitis Virus-Vectored Marburg Vaccine in Cynomolgus Macaques},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16081181}
}
EUVIMED